These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21939466)

  • 1. Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.
    Malzkorn B; Wolter M; Riemenschneider MJ; Reifenberger G
    Brain Pathol; 2011 Nov; 21(6):619-32. PubMed ID: 21939466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
    Xu W; Yang H; Liu Y; Yang Y; Wang P; Kim SH; Ito S; Yang C; Wang P; Xiao MT; Liu LX; Jiang WQ; Liu J; Zhang JY; Wang B; Frye S; Zhang Y; Xu YH; Lei QY; Guan KL; Zhao SM; Xiong Y
    Cancer Cell; 2011 Jan; 19(1):17-30. PubMed ID: 21251613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
    Borodovsky A; Seltzer MJ; Riggins GJ
    Curr Opin Oncol; 2012 Jan; 24(1):83-9. PubMed ID: 22080945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.
    Turcan S; Rohle D; Goenka A; Walsh LA; Fang F; Yilmaz E; Campos C; Fabius AW; Lu C; Ward PS; Thompson CB; Kaufman A; Guryanova O; Levine R; Heguy A; Viale A; Morris LG; Huse JT; Mellinghoff IK; Chan TA
    Nature; 2012 Feb; 483(7390):479-83. PubMed ID: 22343889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in adult diffuse gliomas.
    LeBlanc VG; Marra MA
    Brief Funct Genomics; 2016 Nov; 15(6):491-500. PubMed ID: 27288434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP.
    Moure CJ; Diplas BH; Chen LH; Yang R; Pirozzi CJ; Wang Z; Spasojevic I; Waitkus MS; He Y; Yan H
    Mol Cancer Res; 2019 Oct; 17(10):2042-2050. PubMed ID: 31292202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic modulation of epigenetics in gliomas.
    Venneti S; Thompson CB
    Brain Pathol; 2013 Mar; 23(2):217-21. PubMed ID: 23432648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.
    Han CH; Batchelor TT
    Chin Clin Oncol; 2017 Jun; 6(3):33. PubMed ID: 28705010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
    Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
    Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
    Fukunaga T; Fujita Y; Kishima H; Yamashita T
    PLoS One; 2018; 13(11):e0206552. PubMed ID: 30388142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.
    J Dabrowski M; Wojtas B
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of DNA methylation in adult diffuse gliomas.
    Aoki K; Natsume A
    Brain Tumor Pathol; 2019 Apr; 36(2):84-91. PubMed ID: 30937703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.
    Agnihotri S; Aldape KD; Zadeh G
    Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification of gliomas. Current progress and perspectives].
    Capper D; Reifenberger G
    Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulator dysfunction and oncogene activation in IDH mutant gliomas.
    Flavahan WA; Drier Y; Liau BB; Gillespie SM; Venteicher AS; Stemmer-Rachamimov AO; Suvà ML; Bernstein BE
    Nature; 2016 Jan; 529(7584):110-4. PubMed ID: 26700815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epigenetics and genetics in neuro-oncology.
    Nagarajan RP; Costello JF
    Neurotherapeutics; 2009 Jul; 6(3):436-46. PubMed ID: 19560734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma epigenetics: From subclassification to novel treatment options.
    Gusyatiner O; Hegi ME
    Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
    Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
    Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
    Court F; Le Boiteux E; Fogli A; Müller-Barthélémy M; Vaurs-Barrière C; Chautard E; Pereira B; Biau J; Kemeny JL; Khalil T; Karayan-Tapon L; Verrelle P; Arnaud P
    Genome Res; 2019 Oct; 29(10):1605-1621. PubMed ID: 31533980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.